HGH Frag 176 191 is a synthetic peptide fragment derived from the C terminal region of human growth hormone, investigated for its interactions with lipid metabolism and adipocyte regulatory pathways in preclinical models.
Molecular Composition and Mechanistic Profile
Peptide identity: HGH Frag 176 191 is a sixteen amino acid peptide corresponding to residues 176 to 191 of human growth hormone, commonly represented with an N terminal tyrosine modification as YLRIVQCRSVEGSCGF.
Origin: Synthetic fragment designed to isolate the lipolytic domain of growth hormone while minimizing other hormonal activities.
Mechanistically, HGH Frag 176 191 has been associated with:
Modulation of lipid mobilization and adipocyte related signaling in experimental systems.
Potential interaction with beta 3 adrenergic pathways linked to fat metabolism in laboratory models.
Structural features including a disulfide bridge that support stability in research preparations.
These properties position HGH Frag 176 191 as a tool for studying selective growth hormone fragment effects on metabolic regulation.
Integrated Research Applications
HGH Frag 176 191 is examined in systems focused on lipid metabolism and adipocyte biology. Representative domains include:
Adipocyte and lipolysis models: Investigation of lipid mobilization markers in cultured cells and tissue preparations.
Metabolic pathway studies: Evaluation of effects on energy related signaling in experimental systems.
Comparative growth hormone fragment research: Assessment of activity relative to full length growth hormone in controlled laboratory settings.
Tissue remodeling models: Use as a probe for fragment specific effects in metabolic research.
Overall, HGH Frag 176 191 serves as a research tool for exploring C terminal growth hormone fragment modulation of lipid regulatory networks.
Analytical Validation, Formulation, and Storage
NextGenPeps supplies HGH Frag 176 191 as a high purity research peptide. Typical quality and handling features include:
Purity: ≥99% verified by HPLC.
Formulation: White lyophilized powder in sealed glass vials, intended for reconstitution with appropriate research grade solvent for experimental use only. No dosing guidance is provided for any organism.
Storage: Keep lyophilized material in a cool dark dry environment; long term storage at or below −20 °C. Store reconstituted solutions refrigerated, minimize freeze thaw cycles, and use within laboratory defined stability windows.
NextGenPeps supplies HGH Frag 176 191 as a high purity research peptide intended strictly for controlled laboratory use in vitro or in established animal models, such as murine systems. This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for human consumption, self experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
